Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mami Kikuchi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Anticancer Research|December 30, 2022
Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 YearsMami Kikuchi, Takaaki Fujii, Chikako Honda, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Phase I study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer]Jun Horiguchi, Daisuke Takata, Nana Rokutanda, et al.
Anticancer Research|June 3, 2006
Significance of local recurrence as a prognostic factor in the treatment of breast cancerJun Horiguchi, Yukio Koibuchi, Takashi Yoshida, et al.
Medicine|October 19, 2021
A novel system for teaching the in-plane vascular access technique: A simulation studyMami Kikuchi, Takayuki Asao, Joho Tokumine, et al.
Molecular and Clinical Oncology|March 21, 2014
Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancerKatsunori Tozuka, Jun Horiguchi, Daisuke Takata, et al.
Breast Cancer (Tokyo, Japan)|July 5, 2011
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancerHideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response]Takashi Yoshida, Jun Horiguchi, Yukio Koibuchi, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Papillary lesions of the breast diagnosed using core needle biopsiesHideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Anticancer Research|December 30, 2022
Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 YearsMami Kikuchi, Takaaki Fujii, Chikako Honda, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[Phase I study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer]Jun Horiguchi, Daisuke Takata, Nana Rokutanda, et al.
Anticancer Research|June 3, 2006
Significance of local recurrence as a prognostic factor in the treatment of breast cancerJun Horiguchi, Yukio Koibuchi, Takashi Yoshida, et al.
Medicine|October 19, 2021
A novel system for teaching the in-plane vascular access technique: A simulation studyMami Kikuchi, Takayuki Asao, Joho Tokumine, et al.
Molecular and Clinical Oncology|March 21, 2014
Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancerKatsunori Tozuka, Jun Horiguchi, Daisuke Takata, et al.
Breast Cancer (Tokyo, Japan)|July 5, 2011
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancerHideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response]Takashi Yoshida, Jun Horiguchi, Yukio Koibuchi, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Papillary lesions of the breast diagnosed using core needle biopsiesHideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, et al.
Pageof 3